Rabbit Polyclonal Antibody to AKR1C1
货号:
P41629
别名:
Aldo-keto reductase family 1, member C1, C9; DD1; DDH; DDH1; H-37; HBAB; MBAB; HAKRC; DD1/DD2; 2-ALPHA-HSD; 20-ALPHA-HSD
应用:
WB,IHC
反应种属:
Human,Rat
抗体类型:
Primary antibody
Swissprot:
Q04828
规格:
目录价
在线咨询
Description |
---|
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reaction of progesterone to the inactive form 20-alpha-hydroxy-progesterone. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. |
Specification |
|
---|---|
Aliases | Aldo-keto reductase family 1, member C1, C9; DD1; DDH; DDH1; H-37; HBAB; MBAB; HAKRC; DD1/DD2; 2-ALPHA-HSD; 20-ALPHA-HSD |
Entrez GeneID | 1645; |
Swissprot | Q04828 |
WB Predicted band size | 37kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Rat |
Immunogen | Synthetic peptide corresponding to a region derived from 290-304 amino acids of human aldo-keto reductase family 1, member C1 |
Formulation | Purified antibody in PBS with 0.05% sodium azide. |
Application |
|
---|---|
WB | 1/500-1/2000 |
IHC | 1/50-1/200 |
ELISA | 1:2000-1:5000 |
Product Image
-
Gel: 10%SDS-PAGE Lane1: Human liver cancer tissue lysate Lane2: Human breast infiltrative duct tissue lysate Lane3: Human fetal brain tissue lysate Lysate: 27ug per lane Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 2 minutes
-
The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using 31278 (AKR1C1 Antibody) at dilution 1/30, on the right is treated with the synthetic peptide.